Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat. With cancer accounting for almost 10 million a year, the Global Burden of Disease report (2017) attributed more than 380,000 deaths to head and...
Tag: <span>Blood cancer</span>
Post
Cancer’s reliance on fat could be targeted with new ‘drugs and diet’ treatment
BOSTON UNIVERSITY SCHOOL OF MEDICINE (Boston)–In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific protein (alpha5beta1 integrin) to decrease the number of large bone marrow cells (megakaryocytes) in an experimental model. An increase in megakaryocyte numbers is thought to be the cause of many...
Post
Targeting stem cells that drive aggressive blood cancer
by Peter MacCallum Cancer Centre Peter Mac scientists have found a way to target acute myeloid leukemia (AML) at its source—a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer. Prof Mark Dawson and Dr. Laura MacPherson led the international research team, in collaboration with researchers in Europe...
Post
First-ever US clinical trial of engineered iPSC-derived cell therapy for blood cancer
by University of Minnesota Medical School A new cancer clinical trial has opened at the M Health Fairview University of Minnesota Medical Center that leverages the groundbreaking research on stem cells and natural killer (NK) cells done at the Masonic Cancer Center and applies it to attack acute myeloid leukemia (AML) and B-cell lymphoma. The...
Post
First CAR T cell therapy targeting B cell-activating factor receptor eradicates blood cancers
City of Hope’s research on the new CAR T, published in Science Translational Medicine, offers hope for patients who have relapsed after commercially available CD19 immunotherapy treatments CITY OF HOPE DUARTE, Calif. — The first CAR T cell therapy targeting the B cell-activating factor receptor on cancerous cells eradicated CD19-targeted therapy-resistant human leukemia and lymphoma...
Post
Scientists prove low cost arthritis drug can effectively treat blood cancer sufferers
by University of Sheffield A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study by the University of Sheffield has shown. Led by Dr. Martin Zeidler, from the University of Sheffield’s Department of Biomedical Science and...
Post
Having a parent, sibling, or child with blood cancer increases one’s own risk
by American Society of Hematology New data suggest that people who have a parent, sibling, or child with blood cancer have a higher likelihood of being diagnosed with the disease. The study published online today in Blood offers the first evidence that such familial risks exist across the spectrum of hematologic malignancies. Age of diagnosis, whether the...
Post
New cancer therapy target found in mitochondria for potential treatment of blood cancers
by University of Texas M. D. Anderson Cancer Center A study at The University of Texas MD Anderson Cancer Center identified a new therapeutic target in cancer cells and explains how new anti-cancer drugs called imipridones work by inducing cancer cell death in blood cancers, such as acute myeloid leukemia (AML) and mantle cell lymphoma. The study revealed a target in mitochondria, called caseinolytic protease P (ClpP), which, upon activation, breaks down proteins within mitochondria, a process...
Post
Gene therapy may help fight tough-to-treat blood cancer
by Amy Norton, Healthday Reporter (HealthDay)—A gene therapy that tweaks the immune system might offer hope to people with blood cancer that has resisted standard treatments, a new preliminary trial suggests. The cancer, called multiple myeloma, arises in certain white blood cells. It is currently incurable, but there are treatments that can help people live with the disease for years. However, most people eventually progress, and some fail to respond to the available therapies...
Post
Blood cancer’s Achilles’ heel opens door for new treatments
UNIVERSITY OF EDINBURGH New findings about a fatal form of blood cancer could aid the development of new drugs with significantly less harmful side effects than existing chemotherapy. The discovery could lead to novel treatments that efficiently eliminate blood cancer cells in acute myeloid leukaemia (AML), without harming healthy blood cells. Researchers have discovered how a protein in the body plays a key role in AML...